Todos Medical releases corporate update around validation plan for PCR-based Avian Influenza testing
News release
by
Todos Medical Ltd.
New York
|
February 27, 2023 01:15 PM Eastern Standard Time
Todos Medical CEO Gerald Commissiong joined Proactive's Natalie Stoberman to discuss the validation plan for PCR-based Avian Influenza A (H5N1, bird flu) human testing.
Commissiong also talked about how this new validation plan intertwines with this week's company update and the growth across Todos Medical's projects and subsidiary 3CL Pharma.
Contact Details
Proactive USA
+1 347-449-0879
